Fields & Applications Pharma & Biopharma, Liquid Chromatography, Mass Spectrometry

DAR Analysis of Antibody-Drug Conjugates

contributed by Tosoh | 03/06/2017

The antibody drug market has continued to expand in recent years, and antibody drugs held 6 of the top 10 blockbuster drug spots for 2015. The most promising antibody drug candidates for next-generation biopharmaceuticals are ADCs (antibody-drug conjugates). ADCs have a structure in which a cytotoxic drug is chemically bonded to an antibody (IgG).

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.